ProMIS Neurosciences Inc PMN

Acumenpharma

[FarmerBetsy]

Clinical trials on average for 3 phases run 6-7 years,<br /> ACU193 started phase1 07/2021 which included alzheimers patients measuring blood, csf, etc finishing 07/2023. This phase 1 study is finished . My question is in phase 1 that ended in July 2023 were the patients on ACU193 continuing treatment?

[FarmerBetsy]

Acumenpharma reported year end results this morning. Interesting they have not started phase 2 after wrapping up phay1 last July. 

[bball67]

Something not right. $300M cash and $215m market cap. Under water. Another one bites the dust?

[M101]

You mean your pp bet is flatlining? Because nothing has changed, you knew then that they would be raising again at least for P2 if not P1b, and now the market is thinking it could be at the same price.  If our investor group could have done that placement in the pennies they would have, but they didn't so we probably know the price. It sucks, but so does the whole western free market

[M101]

oops, guess I totally missed the thread, my bad.

[Gbathat]

Yes, very odd. They seemed optimistic on their earnings call. https://seekingalpha.com/article/4680495-acumen-pharmaceuticals-inc-abos-q4-2023-earnings-call-transcript